0
Deep & Emerging Tech·September 28, 2026·1 min read

A look at OpenAI-backed Red Queen Bio, an AI biosecurity startup with $36M raised to design antibody drugs against pathogens, including AI-enabled bioweapons

Share

An OpenAI-backed biosecurity startup designing antibodies against AI-enabled pathogens shows capital flowing into the defense side of dual-use biology. If you operate in biotech or health, assume regulators and partners will increasingly expect AI-native threat modeling and countermeasure capabilities in your stack.